tiprankstipranks
AnaptysBio (ANAB)
NASDAQ:ANAB
US Market
ANAB
AnaptysBio
RESEARCH TOOLSreports
Want to see ANAB full AI Analyst Report?

AnaptysBio (ANAB) Stock News & Sentiment

684 Followers
AnaptysBio Adjusts Fiscal Year-End and Reporting Calendar
Premium
Company Announcements
AnaptysBio Adjusts Fiscal Year-End and Reporting Calendar
3d ago
8K
ANAB
AnaptysBio Split Raises Execution, Cost and Governance Risks as Royalty Dependence and Valuation Uncertainty Grow
Premium
Company Announcements
AnaptysBio Split Raises Execution, Cost and Governance Risks as Royalty Dependence and Valuation Uncertainty Grow
11d ago
ANAB
AnaptysBio Appoints New CFO and Board Director
Premium
Company Announcements
AnaptysBio Appoints New CFO and Board Director
13d ago
8K
ANAB
Joseph Thome Reiterates Buy on AnaptysBio as Royalty-Focused Model and Jemperli Legal Win Support $75 Price Target
Premium
Ratings
Joseph Thome Reiterates Buy on AnaptysBio as Royalty-Focused Model and Jemperli Legal Win Support $75 Price Target
28d ago
ANAB
AnaptysBio Completes First Tracks Spin-Off, Refocuses on Royalties
Premium
Company Announcements
AnaptysBio Completes First Tracks Spin-Off, Refocuses on Royalties
1M ago
8K
ANAB
AnaptysBio: Spin-Off of First Tracks Bio and Strengthened Royalty Profile Create Attractive Risk-Reward Setup
Premium
Ratings
AnaptysBio: Spin-Off of First Tracks Bio and Strengthened Royalty Profile Create Attractive Risk-Reward Setup
2M ago
ANAB
AnaptysBio Advances First Tracks Spin-Off and Governance Changes
Premium
Company Announcements
AnaptysBio Advances First Tracks Spin-Off and Governance Changes
2M ago
8K
ANAB
More ANAB News >

ANAB News on the Web

AnaptysBio price target raised to $90 from $85 at Leerink
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA), Cormedix (CRMD) and AnaptysBio (ANAB)
TipRanks News
Bullish
AnaptysBio Split Raises Execution, Cost and Governance Risks as Royalty Dependence and Valuation Uncertainty Grow
TipRanks News
Bearish
AnaptysBio price target raised to $76 from $60 at UBS
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: AnaptysBio (ANAB), Legend Biotech (LEGN)
TipRanks News
Neutral
AnaptysBio price target raised to $75 from $63 at Barclays
TipRanks News
Bullish
Barclays Remains a Buy on AnaptysBio (ANAB)
TipRanks News
Neutral
ANAB SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing
GuruFocus News
Neutral

News Score - Last 7 Days

Very Negative
ANAB
Sector Average
Media Buzz
This Week2 articles
Weekly Average6.75 articles
News Sentiment
This Week59%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ANAB’s Media Buzz Sentiment?
2 articles about ANAB were published this week. In an average week, 6.75 articles are published.
    What is ANAB’s weekly average amount of articles?
    In an average week, 6.75 articles about ANAB are published.
      What is ANAB’s News Sentiment?
      59% of articles about ANAB were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week